DCLK1 has been identified as a cancer stem cell marker in gastrointestinal, pancreatic, and colorectal cancers, and its overexpression has been associated with tumor progression and poor clinical outcomes in several cancer types [84]. The gene discussed is DCLK1; the disease is cancer.